🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PRL
$PRLD
🔒 US EquitiesPrelude Therapeutics Inc
AVG HISTORICAL GAP
-0.38%
MAX GAP RECORD
-5.82%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PRLD
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PRLD
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 11, 2026 Earnings Release 2026-11-11 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 11, 2026 Earnings Release 2026-08-11 (BEFORE OPEN) |
+2.48%
|
| May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN) |
+0.00%
|
| Mar 10, 2026 Earnings Release 2026-03-10 (BEFORE OPEN) |
-3.24%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN) |
+2.22%
|
| Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN) |
+0.00%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+0.38%
|
| Mar 10, 2025 Earnings Release 2025-03-10 (BEFORE OPEN) |
-2.17%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.2%
Bullish Gaps (3)
Bearish Gaps (5)
Neutral / Flat (4)
📖 Intelligence Summary
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗